“Biopharmaceutical Excipients Market Report is set to have rapid growth due Presence of diversified suppliers and strong research funding in chemicals division at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report
04 September 2019
Visiongain has launched a new pharma report Biopharmaceutical Excipients Market Forecast 2019-2029: By Product (Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols, Carbohydrates), By Region, And Segment Forecasts.
The global Biopharmaceutical Excipients market is poised for rapid growth between 2019 and 2029. Factors such as the growing pharmaceutical industry combined with advances in functional excipients, the growing adoption of orphan drugs and the increasing uptake of biopharmaceuticals are driving the market for pharmaceutical excipients.
Some recent advancements include:
- On December 2018, Roquette Feres (France) signed an agreement with Thermo Fisher Scientific (USA), which gives Thermo Fisher the right to distribute Roquette's product portfolio in the United States and Canada.
- On January 2019, Croda International (United Kingdom) acquired Brenntag Biosector (Denmark) for its portfolio of vaccine adjuvants that would complement Croda's portfolio of pharmaceutical excipients.
- On April 2019, Colorcon, Inc. (United States) signed an agreement with DuPont Nutrition and Biosciences (United States) to improve the current portfolio of CR Alliance products.
- Onn February 2019, Associated British Foods plc (United Kingdom) signed an agreement with Indchem International (India) on the basis of which Indchem will distribute the functional lipid excipient product line of the Associated British Food on the Indian market.
Leading companies featured in the report include ABITEC Corp.; Signet Chemical Corporation Pvt. Ltd.; Roquette; Sigachi Industries Pvt. Ltd.; Meggle AG; Colorcon, Inc.; DFE Pharma; Clariant; IMCD; SPI Pharma; Pharmonix Biological Pvt. Ltd.; Spectrum Chemical Manufacturing Corp., and BASF SE
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
The global wound care market is big, and only set to grow bigger. Currently, estimates show a CAGR of 4.6% in the years to come, with the overall market growing from US$19.8 billion in 2019 to US$24.8 billion by 2024. The industry is ripe with opportunity, with that growth coming from several factors – but most especially growth in emerging …
30 March 2020
Nasal Sprays segment held the largest market share of the global nasal drug delivery technology market in 2019.
30 March 2020
New technologies will be needed to ensure that scaling-up of manufacturing operations can be done effectively once stem cell treatments enter the market.
24 March 2020
As per the latest reports of UNCTAD (United Nations Conference on Trade and Development), COVID-19 pandemic has not only led to tragic human consequences but is projected to cost the global economy $1 trillion in 2020.